Abstract: Xinjiang ranks among the key domestication origins of horses. Local nomadic ethnic groups have a long-standing tradition of consuming equine dairy products, which endows mare-derived dairy matrices with abundant, distinctive and scarce probiotic resources. Equine colostrum is rich in immunoglobulins and growth factors; nevertheless, its pharmacological activities and micro-ecological composition remain poorly characterized. This study aimed to isolate and screen native strains with cholesterol-lowering potential from Xinjiang equine colostrum and conduct a preliminary investigation into their underlying mechanisms. Following isolation and taxonomic identification, one strain of , four strains of , and two yeast strains including and were obtained. All the aforementioned isolates are indigenous microorganisms naturally inhabiting mare colostrum. In vitro assays demonstrated bile salt hydrolase activity and cholesterol clearance rates ranging from 45.07% to 87.14%, with composite probiotic formulations exhibiting superior efficacy. In vivo results demonstrated that the combination formulation significantly reduced serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol ( < 0.05), alleviated hepatic lipid deposition, and regulated gut microbiota composition-notably by enhancing the abundance of beneficial bacteria. It also increased fecal short-chain fatty acids and decreased bile acid levels. These findings demonstrate that the native strains isolated from mare colostrum possess desirable probiotic properties and lipid-lowering bioactivities. Their unique source and natural combinatorial characteristics provide candidate-strain resources for the development of novel functional foods and nutritional supplements.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research focused on isolating and studying probiotic bacteria from equine colostrum in Xinjiang to evaluate their cholesterol-lowering effects.
The study identified specific native strains with potent cholesterol-lowering abilities and examined their mechanisms and benefits both in laboratory tests and live animal models.
Background and Importance
Equine Colostrum: The first milk produced by mares after giving birth; rich in immunoglobulins and growth factors.
Cultural Significance: In Xinjiang, a major region for horse domestication, nomadic groups consume horse dairy products, offering a unique source of probiotic microbes.
Knowledge Gap: Despite its richness, the specific pharmacological effects and microbial composition of equine colostrum were previously not well understood.
Research Goals
Isolate native microbial strains naturally found in Xinjiang mare colostrum.
Evaluate their potential to lower cholesterol based on laboratory tests.
Explore how these strains affect cholesterol metabolism and gut microbiota in live animal experiments.
Methodology
Isolation & Identification: Multiple strains of lactic acid bacteria and yeast were isolated from horse colostrum samples.
In vitro Screening: Tests for bile salt hydrolase activity (an enzyme that can help in cholesterol metabolism) and cholesterol clearance rates (ability to remove cholesterol) were performed.
In vivo Testing: Animal models were given composite probiotic formulations combining the isolated strains to assess effects on serum lipid levels and liver health.
Microbiota Analysis: Gut bacterial compositions were analyzed to understand probiotic influence on beneficial microbes.
Metabolic Measurements: Levels of fecal short-chain fatty acids and bile acids were monitored as indicators of gut health and lipid metabolism.
Key Findings
Several strains with strong cholesterol-lowering potential were identified, demonstrating cholesterol clearance rates between 45.07% and 87.14% in vitro.
The combination (composite) probiotic formulations outperformed individual strains in reducing cholesterol.
Administration of these probiotic mixtures in vivo significantly lowered serum total cholesterol, triglycerides, and LDL (bad cholesterol), indicating improved lipid profiles.
Liver tissue showed reduced fat deposits after probiotic treatment, suggesting protection against fatty liver conditions.
Beneficial changes in gut microbiota were observed, including increased abundance of healthy bacteria.
There was a rise in fecal short-chain fatty acids, important for gut barrier function and metabolism, along with decreased bile acid levels, reflecting improved lipid and gut metabolism.
Implications and Potential Applications
The study identified equine colostrum as a promising source of novel probiotic strains with strong cholesterol-lowering properties.
The unique combination of natural strains derived from this distinctive niche suggests possibilities for synergistic effects beyond individual bacteria.
These findings set the stage for developing new functional foods or dietary supplements targeting cholesterol management and cardiovascular health.
Utilizing probiotics from equine colostrum can contribute to both traditional knowledge and innovative nutrition science.
Conclusion
Native probiotic strains isolated from Xinjiang mare colostrum demonstrate marked cholesterol-lowering activity and beneficial impacts on lipid metabolism and gut microbiota.
These findings highlight the value of equine colostrum as a reservoir of bioactive microbes, with promising applications for promoting health and preventing lipid-related diseases.
Cite This Article
APA
Liu X, Hudayibieergen K, Yeerjiang B, Manaer T, Nabi X.
(2026).
Multiple Probiotic Lactic Acid Bacteria with Marked Cholesterol-Lowering Effects Were Discovered in Equine Colostrum.
Int J Mol Sci, 27(17), 7816.
https://doi.org/10.3390/ijms27177816
School of Pharmacy, Xinjiang Medical University, Urumchi 830017, China.
Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumchi 830017, China.
Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumchi 830017, China.
Hudayibieergen, Kuerdan
School of Pharmacy, Xinjiang Medical University, Urumchi 830017, China.
Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumchi 830017, China.
Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumchi 830017, China.
Yeerjiang, Baheban
School of Pharmacy, Xinjiang Medical University, Urumchi 830017, China.
Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumchi 830017, China.
Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumchi 830017, China.
Manaer, Tabusi
School of Pharmacy, Xinjiang Medical University, Urumchi 830017, China.
Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumchi 830017, China.
Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumchi 830017, China.
Nabi, Xinhua
School of Pharmacy, Xinjiang Medical University, Urumchi 830017, China.
Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumchi 830017, China.
Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumchi 830017, China.
MeSH Terms
Animals
Colostrum / microbiology
Probiotics / pharmacology
Horses
Female
Cholesterol / blood
Cholesterol / metabolism
Lactobacillales / isolation & purification
Gastrointestinal Microbiome
Anticholesteremic Agents / pharmacology
Grant Funding
2024D01D19 / the Key Project Fund of the Autonomous Region Natural Science Foundation
Conflict of Interest Statement
The authors declare no conflicts of interest.
References
This article includes 40 references
Sadowska A, Osiński P, Roztocka A, Chojnacka K.K., Zapora E, Sawicka D, Car H. Statins—From Fungi to Pharmacy. Int. J. Mol. Sci. 2023;25:466.
Teng Y, Wang Y, Tian Y, Chen Y.-y., Guan W.-y., Piao C.-h., Wang Y.-h. Lactobacillus plantarum LP104 ameliorates hyperlipidemia induced by AMPK pathways in C57BL/6N mice fed high-fat diet. J. Funct. Foods 2020;64:103665.
Yeerjiang B, Manaer T, Liu X, Bieerdimulati R, Nabi X. Mechanistic Insights into Lactobacillus harbinensis and Other Probiotics Regulating Lipid Metabolism in T2DM Mice via the PPARγ-LXRα-NPC1L1 Signaling Pathway Based on Multi-Omics Analysis. Metabolites 2026;16:157.
Wu H, Chen J, Guo S, Deng J, Zhou Z, Zhang X, Qi T, Yu F, Yang Q. Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease. Gut Microbes 2025;17:2500099.
Çetin B, Aktaş H. Monitoring probiotic properties and safety evaluation of antilisterial Enterococcus faecium strains with cholesterol-lowering potential from raw Cow’s milk. Food Biosci. 2024;61:104532.
Guo Q, Dong Q, Xu W, Zhang H, Zhao X, He W, He Y, Zhao G. Metabolite profiling of camel milk and the fermentation bacteria agent TR1 fermented two types of sour camel milk using LC-MS in relation to their probiotic potentials. Heliyon 2024;10:e35801.
Yu L, Manaer T, Xinhua N. Interactions of lactic acid bacterium and yeasts isolated from Xinjiang traditional fermented dairy products. Sci. Technol. Food Ind. 2015;36:186–189.
Zhao X, Xie K, Wang Y, He Y, Wei H, Tao X. Screening of probiotic strains from human breast milk and evaluation of their potential anti-obesity properties. J. Funct. Foods 2025;132:106969.
Bhushan B, Sakhare S.M., Narayan K.S., Kumari M, Mishra V, Dicks L.M.T. Characterization of Riboflavin-Producing Strains of Lactobacillus plantarum as Potential Probiotic Candidate through in vitro Assessment and Principal Component Analysis. Probiotics Antimicrob. Proteins 2020;13:453–467.
Zhang W, Lai S, Zhou Z, Yang J, Liu H, Zhong Z, Fu H, Ren Z, Shen L, Cao S.Z.. Screening and evaluation of lactic acid bacteria with probiotic potential from local Holstein raw milk. Front. Microbiol. 2022;13:918774.
Song Y, Li A, Xu S, Ma L, Zhu H. Isolation, Screening, and Probiotic Function Evaluation of Lactic Acid Bacteria with Isolation, Screening, and Probiotic Function Evaluation of Lactic Acid Bacteria with. Mod. Food Sci. Technol. 2022;38:44–52.
Campedelli I, Mathur H, Salvetti E, Clarke S, Rea M.C., Torriani S, Ross R.P, Hill C, O’Toole P.W. Genus-Wide Assessment of Antibiotic Resistance in Lactobacillus spp.. Appl. Environ. Microbiol. 2019;85:e01738-18.
Ali S, Rasool S, Vajihe A. Probiotic Lactobacillus and the potential risk of spreading antibiotic resistance: A systematic review. Res. Pharm. Sci. 2023;18:468–477.
Hummel AS, Hertel C, Holzapfel WH, Franz CM. Antibiotic resistances of starter and probiotic strains of lactic acid bacteria.. Appl. Environ. Microbiol. 2007;73:730–739.
Agolino G, Pino A, Vaccalluzzo A, Cristofolini M, Solieri L, Caggia C, Randazzo CL. Bile salt hydrolase: The complexity behind its mechanism in relation to lowering-cholesterol lactobacilli probiotics.. J. Funct. Foods. 2024;120:106357.
MaLiNa K, Bao Y. Screening, Identification of Cholesterol-lowering Abilities Screening, Identification of Cholesterol-lowering Abilities Screening, Identification of Cholesterol-lowering Abilities.. J. Chin. Inst. Food Sci. Technol. 2021;21:266–275.
Ramasamy K, Abdullah N, Wong M, Karuthan C, Ho YW. Bile salt deconjugation and cholesterol removal from media by Lactobacillus strains used as probiotics in chickens.. J. Sci. Food Agric. 2010;90:65–69.
Kudaibergenova A, Begdildayeva N, Amirkhanova A, Nurgazina A, Ospanova A, Kondybayev A, Akhmetsadykova S, Jumagaziyeva A, Iskakbayeva Z, Jumabayeva S. Probiotic Characterization of Lactic Acid Bacteria Isolated from Traditional Fermented Camel Milk and Horse Milk Products.. ES Food Agrofor. 2025;21:1763.
Zhu Q, Xing G, Shan Z, Luo S, Mao Y, Ren L, Wang T, Ma Y, Liu Y, Liu J. Screening and Genome Analysis of Potential Probiotic Lactiplantibacillus plantarum with Anti-Listeria monocytogenes Activity from Traditional Fermented Foods.. Microorganisms 2025;13:2104.
Kanimozhi R, Sangavi R, Malligarjunan N, Gowrishankar S. Screening, isolation, identification and evaluation of bacteria with probiotic potential from traditional palmyra palm nectar.. Front. Cell. Infect. Microbiol. 2025;15:1685639.
Gao Y, Huang F, Wang J, Wang H, Kong B, Qin L, Chen Q. Research Progress on Cholesterol-Lowering Mechanism and Evaluation Strategies for Probiotics.. Food Sci. 2023;44:322–329.
Qu T, Yang L, Wang Y, Jiang B, Shen M, Ren D. Reduction of serum cholesterol and its mechanism by Lactobacillus plantarum H6 screened from local fermented food products.. Food Funct. 2020;11:1397–1409.
Wen JJ, Li MZ, Gao H, Hu JL, Nie QX, Chen HH, Zhang YL, Xie MY, Nie SP. Polysaccharides from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorate metabolic disorders and gut microbiota change in obese rats.. Food Funct. 2021;12:2617–2630.
Louis P, Young P, Holtrop G, Flint HJ. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: Acetate CoA-transferase gene.. Environ. Microbiol. 2010;12:304–314.
Melanie LS, Yifan X, Manolo L, Alvarez GF, Daphne K, Chandler D, Uku K, Sarah A, Manon L, Pascale F. The effects of Aronia berry (poly)phenol supplementation on arterial function and the gut microbiome in middle aged men and women: Results from a randomized controlled trial.. Clin. Nutr. 2022;41:2549–2561.
Li Y, Chen M, Ma Y, Yang Y, Cheng Y, Ma H, Ren D, Chen P. Regulation of viable/inactivated/lysed probiotic Lactobacillus plantarum H6 on intestinal microbiota and metabolites in hypercholesterolemic mice.. npj Sci. Food. 2022;6:50.
Chen Y, Deng Q, Xu J, Wang X, Hu C, Tang H, Huang F. Sinapic acid and resveratrol alleviate oxidative stress with modulation of gut microbiota in high-fat diet-fed rats. Food Res. Int. 2018;116:1202–1211.
Wei X, Tao J, Xiao S, Jiang S, Shang E, Zhu Z, Qian D, Duan J. Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. Sci. Rep. 2018;8:3685.
Wang G, Xia C, Li W, Lin Z, Yong X, Lian A. Diverse conditions contribute to the cholesterol-lowering ability of different Lactobacillus plantarum strains. Food Funct. 2020;12:1079–1086.
Li H, Liu F, Lu J, Shi J, Guan J, Yan F, Li B, Huo G. Probiotic Mixture of Lactobacillus plantarum Strains Improves Lipid Metabolism and Gut Microbiota Structure in High Fat Diet-Fed Mice. Front. Microbiol. 2020;11:512.
Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: Metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 2022;21:236–247.
Na R, Ru Y, Liu W, MengHe B. Isolation and identification of lactic acid bacteria in koumiss in different regions Central and East Asia and screening of excellent strains. Food Ferment. Ind. 2023;49:120–126.
Xiao C, Yue X, Wu X, Ye Z, Yang F. In Vitro Probiotic Properties and Antioxidant Activity of Lactobacillus945 crispatus DY38 from Goats. Chin. J. Anim. Nutr. 2025;37:1340–1353.
Chen D, Cheng Y, Ren C, Chen C, Qu H, Wa Y, Yan X, Chen X, Huang Y, Gu R. Capability of Lactobacillus to Tolerate Digestive Stress and Effect of Digestive Stress on Its Intestinal Adhesion Capacity. Food Sci. 2022;43:143–150.
Samedi L, Charles AL. Isolation and characterization of potential probiotic Lactobacilli from leaves of food plants for possible additives in pellet feeding. Ann. Agric. Sci. 2019;64:55–62.
Yang Q, Wang R, Sun Y, Liu X, Li Q, Ma Y. Screening, identification and properties of cholesterol lowering lactic acid bacteria. Food Ferment. Ind. 2023;49:46–52.